Physician profile
David A Thomas
NPI 1104870146
$2,076.92
in general payments reported to CMS, 2019-2025
17 companies · $727 in 2025
The $727 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $26.27 · 2021: $80.27 · 2022: $320 · 2023: $407 · 2024: $405 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,435 · Education: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,435.38 |
| Education | $103.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $373.61 | 2023-2025 | |
| Sk Life Science, INC. | $276.35 | 2023-2025 | |
| Abbvie INC. | $246.60 | 2021-2025 | Botox |
| Teva Pharmaceuticals USA, INC. | $215.74 | 2019-2023 | |
| Biogen, INC. | $203.01 | 2021-2025 | Vumerity, Tysabri |
| Novartis Pharmaceuticals Corporation | $158.55 | 2023-2025 | Kesimpta |
| Supernus Pharmaceuticals, INC. | $154.99 | 2022 | |
| Harmony Biosciences LLC | $117.85 | 2022-2024 | Wakix |
| Neuronetics, INC. | $89.20 | 2022 | |
| Ucb, INC. | $54.02 | 2025 | Rystiggo, Zilbrysq |
| Eisai INC. | $45.11 | 2025 | |
| Axsome Therapeutics, INC. | $40.11 | 2024 | Sunosi |
| Alexion Pharmaceuticals, INC. | $24.63 | 2025 | Ultomiris |
| Lundbeck LLC | $23.98 | 2025 | Rexulti |
| Genentech USA, INC. | $21.89 | 2025 | Ocrevus Zunovo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.74 | 2025 | Kisunla |
| Sunovion Pharmaceuticals INC. | $13.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.